CN103739586A - Method for extracting diterpenoid compounds from Blumea aromatic DC. - Google Patents
Method for extracting diterpenoid compounds from Blumea aromatic DC. Download PDFInfo
- Publication number
- CN103739586A CN103739586A CN201310588947.4A CN201310588947A CN103739586A CN 103739586 A CN103739586 A CN 103739586A CN 201310588947 A CN201310588947 A CN 201310588947A CN 103739586 A CN103739586 A CN 103739586A
- Authority
- CN
- China
- Prior art keywords
- diterpene
- lower alcohol
- extract
- ethyl acetate
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a method for extracting diterpenoid compounds from Blumea aromatic DC., belongs to the technical field of medicines, and discloses a method for preparing diterpenoid compounds by extracting the diterpenoid compounds from the aerial part of Blumea aromatic DC.. The method is characterized in that crude medicinal powder is extracted through high-concentration lower alcohol (like methanol and ethanol, same below), the obtained extract liquid is concentrated to obtain a concentrate, the concentrate is dispersed by a small amount of water to obtain a dispersion, the dispersion is extracted by petroleum ether to remove low-polarity components (like chlorophyll), the obtained petroleum ether extraction liquid is extracted by ethyl acetate, the solvent of the obtained ethyl acetate extraction liquid is recovered, the solvent recovered substance is dissolved by a proper amount of the lower alcohol, the obtained solution sequentially goes through an MCI resin, polyamide and a SephadexLH-20 gel chromatograph column, and is eluted by the lower alcohol, a specific color section is collected, the lower alcohol solution low temperature crystallization and recrystallization of the specific color section are carried out to obtain diterpenoid compound crystals or amorphous powder. The compounds have latent medicinal values. The method has the advantages of good repetitiveness, stable content and high purity of the extracted compounds, simple technology, and low cost, and is of great significance to popularize and apply the Blumea aromatic DC..
Description
Technical field
The present invention relates to Natural Medicine Chemistry field, be specifically related to a kind of method of extracting diterpene-kind compound from strong medicine mountain breeze.
Background technology
Mountain breeze is composite family Herba Blumeae Balsamiferae platymiscium fragrance virtue Herba Blumeae Balsamiferae Blumea aromatica DC., is Zhuang nationality in Guangxi medicinal herbs most in use, medicinal over-ground part, pungent, the micro-hardship of taste, warm in nature, gas perfume (or spice), have dispel rheumatism, swelling and pain relieving, clearing and activating the channels and collaterals effect.Mountain breeze is the main raw material of the rheumatism series product such as the famous Chinese patent medicine in Guangxi ' Huatuo's wind pain is precious ', ' effective rheumatism medicine medicinal liquor '.
Although mountain breeze in Guangxi utilization among the people extensively and have longer history, to the chemical research of its system, carry out very less.Only have at present inventor team this medicinal material ethyl acetate extract to be carried out to the pertinent literature of chemical constitution study, also only have a small amount of clinical and pharmacological action report, as: the externally used medicinal liquor being made into is dispelled rheumatism, the toothpaste anti-inflammation hemostasia of making etc.And the present invention finds a series of labdane diterpenes compounds that a large amount of skeletons are identical first from Herba Blumeae Balsamiferae platymiscium.
Diterpene-kind compound distributes very wide in vegitabilia, many diterpene containing oxygen derivatives have good biological activity, as rographolide, Triptolide, bilobalide etc., some has been clinical conventional medicine, particularly, thering is obvious effect aspect antitumor and anti-immune disease, there is good DEVELOPMENT PROSPECT.Labdane type diterpenoids is the parent nucleus that forms take the perhydronaphthalene cyclization diterpene as basic framework, in vegitabilia, Ladanum alkane exists in a large number, in Coleus forskohlii Briq. sheath stamen florigen (forskolin), Herba Andrographis in rographolide all belong to Ladanum alkane diterpene structure.That rographolide has is antibacterial, the effect of anti-inflammatory, in recent years finds that there is again the activity of cytodifferentiation induced activity and anti-toxic liver injury, has the application of wide model in medicine.Forskolin (forskolin) is used for the treatment of cardiovascular disorder clinically, glaucoma, bronchial asthma etc., it can also regulate various tissues by activated adenyl cyclase simultaneously, it is a kind of activator of other medicines, only in plant Coleus forskohlii Briq., find at home at present, and that diterpene-kind compound in mountain breeze has skeleton structure is completely identical with fosikelin, content is also high, mountain breeze is easier to establishing in large scale, therefore the diterpene-kind compound in mountain breeze has very large pharmaceutical prod potentiality to be exploited, and the present invention extracts the labdane diterpenes compound of preparation from mountain breeze, also may be the effective constituent of strong medicine mountain breeze.
Summary of the invention
Mountain breeze (Blumea aromatica DC) medicinal material, after suitably pulverizing, with 70% to 100% lower alcohol (methyl alcohol, ethanol, lower same), in static state or dynamically, room temperature or heating (comprise dipping, ultrasonic, diacolation, reflux, microwave etc.) extract 3 times, extracting solution decompression or air distillation are reclaimed alcoholic solvent to 1.10~1.50/30 ℃ of relative densities, adding 0.2 to 5 times of volume water mixes, with equal-volume petroleum ether extraction three times, then mother liquor changes and is extracted with ethyl acetate three times, the concentrated organic solvent of removing of ethyl acetate extraction part decompression or atmospheric evaporation, obtain medicinal extract.Appropriate lower alcohol (methyl alcohol for medicinal extract, ethanol, down together) after dissolving, through MCI macroporous resin column chromatography, with 50%, 85%, 95% ethanol wash-out successively, collect concentrated 85% alcohol elution, then with polyamide column chromatography, remove the sour phenolic constituents such as tannin and flavones, again through sephadex LH-20 dextrane gel column chromatography, with lower alcohol wash-out, under TLC or HPLC guidance, collect special color section eluting solvent, elutriant reclaims alcoholic solvent and obtains amber fluid extract, with moisture lower alcohol dissolution process generation crystallization, obtain crystallization or unformed Powdered diterpene compound sterling with moisture lower alcohol recrystallization.Recrystallization mother liquor can be used for next batch and recycles.
Accompanying drawing explanation
Fig. 1 is compound 1 (aromaticasin B) extraction process general flow chart
Fig. 2 is compound 1 (aromaticasin B)
1h-NMR spectrogram (CDCl
3)
Fig. 3 is compound 1 (aromaticasin B)
13c-NMR spectrogram (CDCl
3)
Fig. 4 is that the single crystal diffraction of compound 1 (aromaticasin B) records relative configuration figure
Concrete embodiment 1
The extraction of Aromaticasin B separates
Mountain breeze (Blumea aromatica DC) medicinal material coarse powder 500g extracts 3 times by 85% alcohol immersion, each 6 times of amount (m/v, g/ml), soak 5 days, extracting solution suction filtration merges, filtrate recycling ethanol is 1.25/30 ℃ to relative density, add 2 times of volume water and stir evenly rear equal-volume petroleum ether extraction 3 times of using, after extraction liquid reclaims solvent, residue discards; Equal-volume ethyl acetate extraction 3 times for mother liquor after extraction, acetic acid ethyl acetate extract reclaims solvent and obtains medicinal extract, the a small amount of dissolve with methanol of medicinal extract, through MCI post with 85% ethanol elution, after reclaiming solvent, gained medicinal extract is through sephadex-LHX20 dextrane gel column chromatography, after methanol-eluted fractions, under instructing, TLC collects aromaticasin B high-content elute soln, reclaim methyl alcohol, obtain amber fluid extract, use ethanolic soln heating for dissolving, let cool crystallization, 80% ethyl alcohol recrystallization, obtains whitening compound 1 (aromaticasin B) crystallization.
The Structural Identification of Aromaticasin B
Compound 1 is white cube crystallization.By ESI-MS, determine that its its molecular formula is: C
20h
34o
3, through two dimensional NMR technology such as HSQC, HMBC, determined compound two dimensional structure, relative configuration warp
1h-
1it is by name that H COSY and X-ray single crystal diffraction have obtained confirmation (accompanying drawing 4) chemistry: (4R, 5R, 8R, 9R, 10S, 12R, 13S)-2 β, 18-dihydroxyl-14-alkene-tear pool ether (or its enantiomorph), English name is decided to be: Aromaticasin B, Chinese name is decided to be: mountain breeze ether second (seeing Aromaticasin B chemical structural formula).
Compound 1 nuclear magnetic data is as follows:
1H?NMR(600MHz,in?CDCl
3)δ(ppm):
1.36(1H,m,H-1a),1.20(1H,m,H-1b),1.60(1H,overlapped,H-2a),1.46(1H,m,H-2b),0.83(1H,td,J=12.6,3.0,H-3a),1.52(1H,m,H-3b),1.60(1H,overlapped),1.76(1H,td,J=13.2,3.0,H-6a),1.60(1H,overlapped,H-6b),1.71(1H,td,J=12.6,3.0,H-7a),1.39(1H,td,J=13.2,4.2,H-7b),1.25(1H,m,H-9),1.51(1H,m,H-11a),1.24(1H,overlapped,H-11b),4.01(1H,t,J=3.0,H-12),6.00(1H,dd,J=11.4,18.6,H-14),4.91(1H,d,J=11.4,H-15a),4.90(1H,d,J=18.6,H-15b),1.13(3H,s,H-16),1.18(3H,d,J=0.6,H-17),0.67(3H,s,H-18),3.35,3.04(2H,d,J=10.8,H-19),0.72(3H,s,H-20).
13C?NMR(151MHz,in?CDCl
3)δ(ppm):
146.1(C-14),109.6(C-15),75.2(C-8),75.1(C-13),70.9(C-19),68.1(C-12),48.8(C-11),41.4(C-7),37.5(C-3),36.6(C-4),35.3(C-10),34.3(C-1),25.9(C-16),23.3(C-17),22.6(C-6),18.7(C-11),16.8(C-2),16.1(C-18),15.2(C-20).
Claims (7)
1. from the over-ground part of Zhuang herbal medicine mountain breeze (Blumeaaromatica DC.), extract the method for preparing diterpene (falling diterpene) compounds, it is characterized in that medicinal material coarse powder passes through high density lower alcohol (as methyl alcohol, ethanol, lower same) extract, after extracting solution is concentrated, use a small amount of water-dispersion, through petroleum ether extraction, remove low polarity component (as chlorophyll etc.), be extracted with ethyl acetate again, after acetic acid ethyl acetate extract recovery solvent is concentrated, appropriate lower alcohol dissolves, successively through MCI resin, SephadexLH-20 gel chromatographic columns, with low-alcohol solution wash-out, collect special color section, recovery solvent is concentrated, obtain fluid extract, the aqueous solution of lower alcohol is processed crystallization, recrystallization can obtain diterpene-kind compound crystallization or unformed powder.
3. its substituting group of diterpene-kind compound claimed in claim 2 can be as follows:
R
1:-CH
2oH ,-CH
2oCH
3or-COOCH
3,-COOH
R
2: R
3, R
6, R
7: can be-OH ,-OCH
3,-OCOCH
3,=O
R
5:-OH、-OCH
3、-OCOCH
3
R4:-CH=CH
2、-CHOHCH
3、-CHOHCH
2OH
4. compound claimed in claim 2 can be also that R4 sloughs, and epoxy bond fracture and form a series of contain 18 carbon atoms diterpenes derivative falls.
Compound claimed in claim 2 can be also dehydration and be formed on two keys of 1,2,3,11 or 12.
5. the preferred following compound 1 of diterpene-kind compound claimed in claim 2 (I), its molecular formula is: C
20h
34o
3, chemistry is by name: (4R, 5R, 8R, 9R, 10S, 12R, 13S)-2 β, and 18-dihydroxyl-14-alkene-tear pool ether (or its enantiomorph), English name is decided to be: Aromaticasin B, Chinese name is decided to be: mountain breeze ether second.
6. the extraction and separation process of diterpene-kind compound claimed in claim 1 is:
6.1 starting material are the over-ground part of Herba Blumeae Balsamiferae platymiscium mountain breeze (Blumea aromatica DC.), and its meal adopts high density lower alcohols (methyl alcohol, ethanol, lower same) to extract;
6.2 extracting solutions reclaim after alcoholic solvent, residual solution adds 0.2 to 5 times of volume that water is equivalent to residual solution, fully suspendible, suspension is used respectively sherwood oil, ethyl acetate fully extracts, collect ethyl acetate part, recovery is removed organic solvent and is made ethyl acetate extract, medicinal extract dissolves with a small amount of lower alcohol, MCI removes pigment, polymeric amide removes after the sour phenolic constituents such as flavones, upper dextrane gel column chromatography, lower alcohol wash-out, at thin-layer chromatography, under the guidance of high performance liquid chromatography, collect particular elutriated part, reclaim alcoholic solvent, obtain amber total diterpene fluid extract, the aqueous solution with lower alcohol is processed crystallization, recrystallization obtains the crystallization of diterpene-kind compound monomer or solid diterpene mixture,
6.3 explanations about said extracted separating technology:
1) described in 6.1, the concentration of lower alcohols is 70% to 100%;
2) described in 6.1, extracting method can be: the several different methods such as backflow, dipping, diacolation, ultrasonic, microwave extraction;
3) described in 6.2, reclaim after alcoholic solvent, residual solution relative density is 1.1~1.50/30 ℃;
4) the preferred sephadex-LHX20 of dextrane gel for chromatography described in 6.2.
7. described in claim 1, diterpene-kind compound can be used as reference substance for medicinal material mountain breeze and formulation products quality control thereof, also has potential pharmaceutical value.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310588947.4A CN103739586A (en) | 2013-11-22 | 2013-11-22 | Method for extracting diterpenoid compounds from Blumea aromatic DC. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310588947.4A CN103739586A (en) | 2013-11-22 | 2013-11-22 | Method for extracting diterpenoid compounds from Blumea aromatic DC. |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103739586A true CN103739586A (en) | 2014-04-23 |
Family
ID=50496674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310588947.4A Pending CN103739586A (en) | 2013-11-22 | 2013-11-22 | Method for extracting diterpenoid compounds from Blumea aromatic DC. |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103739586A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758335A (en) * | 2015-04-30 | 2015-07-08 | 广西壮族自治区药用植物园 | Preparation method and application of Blumea aromatica DC. ethyl acetate extract with anti-inflammatory activity |
CN105601516A (en) * | 2016-03-31 | 2016-05-25 | 河南中医学院 | Labdane-type diterpene compound extracted and separated from fructus podophylli and preparation method and application of labdane-type diterpene compound |
CN105669415A (en) * | 2016-03-31 | 2016-06-15 | 河南中医学院 | Method for extracting and separating labdane diterpenes from Himalayan mayapple fruit and application thereof |
CN106248852A (en) * | 2016-08-29 | 2016-12-21 | 广西壮族自治区药用植物园 | By measuring the method that the content of fragrance virtue Herba Blumeae Aromaticae element identifies the Blumea aromatic DC. true and false |
CN107383043A (en) * | 2017-08-03 | 2017-11-24 | 武汉天植生物技术有限公司 | The method that Qinghaosu II is extracted from sweet wormwood |
CN110988182A (en) * | 2019-12-19 | 2020-04-10 | 广西壮族自治区药用植物园 | Quality detection method of Zhuang medicine ethnic medicine Huatuo Fengtongbao capsule |
CN112028867A (en) * | 2020-09-10 | 2020-12-04 | 广西壮族自治区药用植物园 | Tricyclic diterpene compound and extraction method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142628A (en) * | 2013-02-05 | 2013-06-12 | 广西壮族自治区药用植物园 | Application of diterpenoid compound in treating hepatitis c virus (HCV) |
-
2013
- 2013-11-22 CN CN201310588947.4A patent/CN103739586A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142628A (en) * | 2013-02-05 | 2013-06-12 | 广西壮族自治区药用植物园 | Application of diterpenoid compound in treating hepatitis c virus (HCV) |
Non-Patent Citations (4)
Title |
---|
ANDRES GARCIA-GRANADOS ET AL.: "In Vitro Action of ent-Manoyl Oxides against Leishmania donovani", 《J. NAT. PROD. 》, vol. 60, no. 1, 22 January 1997 (1997-01-22), pages 13 - 16 * |
YEN-CHENG LI ET AL.: ""Labdane-Type Diterpenoids from the Wood of Cunninghamia konishii"", 《CHEM. PHARM. BULL.》, vol. 50, no. 4, 10 July 2002 (2002-07-10), pages 498 - 500 * |
蓝鸣生等: ""壮药山风的化学成分研究"", 《中草药》, vol. 43, no. 9, 12 September 2012 (2012-09-12), pages 1708 - 1711 * |
蓝鸣生等: ""山风乙酸乙酯部位的化学成分研究"", 《中药材》, vol. 35, no. 2, 25 February 2012 (2012-02-25), pages 229 - 231 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758335A (en) * | 2015-04-30 | 2015-07-08 | 广西壮族自治区药用植物园 | Preparation method and application of Blumea aromatica DC. ethyl acetate extract with anti-inflammatory activity |
CN105601516A (en) * | 2016-03-31 | 2016-05-25 | 河南中医学院 | Labdane-type diterpene compound extracted and separated from fructus podophylli and preparation method and application of labdane-type diterpene compound |
CN105669415A (en) * | 2016-03-31 | 2016-06-15 | 河南中医学院 | Method for extracting and separating labdane diterpenes from Himalayan mayapple fruit and application thereof |
CN105669415B (en) * | 2016-03-31 | 2017-10-03 | 河南中医学院 | A kind of method and its application that separation labdane diterpenes compound is extracted from Himalayan mayapple fruit |
CN106248852A (en) * | 2016-08-29 | 2016-12-21 | 广西壮族自治区药用植物园 | By measuring the method that the content of fragrance virtue Herba Blumeae Aromaticae element identifies the Blumea aromatic DC. true and false |
CN106248852B (en) * | 2016-08-29 | 2017-11-21 | 广西壮族自治区药用植物园 | The method that content by determining fragrance virtue Herba Blumeae Aromaticae element identifies the Blumea aromatic DC. true and false |
CN107383043A (en) * | 2017-08-03 | 2017-11-24 | 武汉天植生物技术有限公司 | The method that Qinghaosu II is extracted from sweet wormwood |
CN110988182A (en) * | 2019-12-19 | 2020-04-10 | 广西壮族自治区药用植物园 | Quality detection method of Zhuang medicine ethnic medicine Huatuo Fengtongbao capsule |
CN112028867A (en) * | 2020-09-10 | 2020-12-04 | 广西壮族自治区药用植物园 | Tricyclic diterpene compound and extraction method and application thereof |
CN112028867B (en) * | 2020-09-10 | 2022-09-23 | 广西壮族自治区药用植物园 | Tricyclic diterpene compound and extraction method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103739586A (en) | Method for extracting diterpenoid compounds from Blumea aromatic DC. | |
CN101899070B (en) | Preparation method for fast separating flavonoid glycosides from oil-tea-cakes with medium pressure column | |
CN102351824B (en) | Method for preparing lactuca indica and lactucin | |
CN104031013B (en) | A kind of utilize the isolated and purified method preparing salvianolic acid B and rosmarinic acid of high speed adverse current chromatogram | |
CN102746362A (en) | Method for extracting refined astragaloside from astragaliradix | |
CN105585471A (en) | Extraction method of active ingredients of isodon amethystoides | |
CN105294623A (en) | Sesquiterpene lactone compound, preparation method and application thereof | |
CN108299453A (en) | A method of detaching psoralen, Isopsoralen and Bakuchiol from psoralea corylifolia | |
CN105061448A (en) | Method for extracting, separating and purifying three kinds of coumarin from dahurian angelica root | |
CN109694366A (en) | A kind of method of separating-purifying Tamarix austro effective component | |
CN106831909B (en) | The extracting method of double benzene pyrrones compounds in rhizoma anemarrhenae fibrous root | |
CN106632577B (en) | A kind of Ursane triterpenoid saponin and its preparation process in masson pine branch | |
CN103086967B (en) | Alkaloid having type 1 skeleton in Nigellaglandulifera Freyn grass seeds, and its preparation method | |
CN106831936B (en) | The method that tanshinone IIA and dihydrotanshinone I are prepared using middle high-pressure preparation liquid phase method | |
CN106674239B (en) | A kind of Viburnum opulus Linn. var. calvescens (Rehd.) Hara f. calvescens branches and leaves lignanoid and extracting method and purposes | |
CN104987952A (en) | Method for extracting volatile oil and salidroside from rhodiola whole herb | |
CN101982466A (en) | Method for extracting isoflavonoids compound in all-grass of Twining Rhynchosia with ionic liquid | |
CN101085794B (en) | Method for preparing 10-deacetyl asperulosidic acid methyl ester | |
CN103102305B (en) | Alkaloid of skeleton type 2 in nigella glandulifera preyn and preparation method of alkaloid | |
CN116332825A (en) | Preparation method of aristolochia lactam component in houttuynia cordata | |
CN106008219A (en) | Sesquiterpenoid compound, preparation method of sesquiterpenoid compound and application of sesquiterpenoid compound to preparation of anti-rotavirus medicines | |
CN105777680A (en) | Pharmaceutical composition of doxorubicin hydrochloride and medical application of pharmaceutical composition of doxorubicin hydrochloride | |
CN107043363B (en) | A method of extracting scopoletin from poppyhead stool fruit | |
CN1869056A (en) | Method of extracting and separating ginseng saponine mixture from ginseng leaf | |
CN103483410B (en) | Xanthoceraside preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140423 |